Publicacións en colaboración con investigadores/as de University of Bristol (14)

2018

  1. The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale: Validation in six countries

    Rheumatology (United Kingdom), Vol. 57, Núm. 2, pp. 300-308

2017

  1. Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: An analysis of 1588 patients

    Rheumatology (United Kingdom), Vol. 56, Núm. 9, pp. 1573-1578

2016

  1. Translating patient reported outcome measures: Methodological issues explored using cognitive interviewing with three rheumatoid arthritis measures in six European languages

    Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1009-1016

2015

  1. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1

    Nature Communications, Vol. 6

2014

  1. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2012

  1. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223

  2. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196

2011

  1. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 3, pp. 404-413

  2. American college of rheumatology/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

    Arthritis and Rheumatism, Vol. 63, Núm. 3, pp. 573-586

  3. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: A EULAR initiative

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 6, pp. 935-942

2009

  1. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: A EULAR initiative

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 11, pp. 1680-1685

2008

  1. Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients withd-heumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 10, pp. 1365-1373

  2. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

    Arthritis Care and Research, Vol. 59, Núm. 10, pp. 1371-1377

  3. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 10, pp. 1360-1364